The CEO of Novo Nordisk took questions for more than two hours during a Senate Health Committee hearing focused on addressing ...
For the millions of people living with diabetes or obesity, drugs like Ozempic and Wegovy can significantly improve their ...
The CEO of Novo Nordisk wouldn’t commit to lowering the prices of Ozempic and Wegovy during a Senate hearing Tuesday, despite ...
What I am asking you is, if you don’t act, 40,000 people a year could die? Is this acceptable to you?” the senator asked.
The boss of the Danish pharmaceutical giant behind the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy promised ...
Sen. Bernie Sanders mentioned that North Carolina ended coverage of Wegovy for state employees due to the cost.
The maker of diabetes and weight-loss drugs Ozempic and Wegovy was in the hot seat Tuesday as Vermont Sen. Bernie Sanders ...
Sen. Bernie Sanders grilled the CEO of Novo Nordisk, the maker of Ozempic, over the price of the breakthrough diabetes and weight loss drug.
This realization led to a breakthrough that could revolutionize how the agriculture industry deals with waste, with a ...
U.S. senators questioned Novo Nordisk CEO Lars Fruergaard Jørgensen about the high costs of the company's GLP-1 drugs, which include popular weight-loss drugs Wegovy and Ozempic. It comes after North ...
Novo Nordisk charges $969 per month for Ozempic in the U.S., compared to $155 per month in Canada and $59 in Germany.